ES386601A1 - Un procedimiento de resolucion de 2-(oclorofenil) - 2- me- tilamino-ciclohexanona racemica. - Google Patents

Un procedimiento de resolucion de 2-(oclorofenil) - 2- me- tilamino-ciclohexanona racemica.

Info

Publication number
ES386601A1
ES386601A1 ES386601A ES386601A ES386601A1 ES 386601 A1 ES386601 A1 ES 386601A1 ES 386601 A ES386601 A ES 386601A ES 386601 A ES386601 A ES 386601A ES 386601 A1 ES386601 A1 ES 386601A1
Authority
ES
Spain
Prior art keywords
methylaminocyclohexanone
chlorophenyl
tartaric acid
isomer
racemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES386601A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES386601A1 publication Critical patent/ES386601A1/es
Expired legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES386601A 1969-12-19 1970-12-18 Un procedimiento de resolucion de 2-(oclorofenil) - 2- me- tilamino-ciclohexanona racemica. Expired ES386601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88679969A 1969-12-19 1969-12-19

Publications (1)

Publication Number Publication Date
ES386601A1 true ES386601A1 (es) 1974-01-16

Family

ID=25389797

Family Applications (1)

Application Number Title Priority Date Filing Date
ES386601A Expired ES386601A1 (es) 1969-12-19 1970-12-18 Un procedimiento de resolucion de 2-(oclorofenil) - 2- me- tilamino-ciclohexanona racemica.

Country Status (9)

Country Link
JP (1) JPS4948542B1 (de)
BE (1) BE760492A (de)
CH (1) CH535201A (de)
DE (1) DE2062620A1 (de)
ES (1) ES386601A1 (de)
FR (1) FR2081388B1 (de)
GB (1) GB1330878A (de)
NL (1) NL7018334A (de)
ZA (1) ZA708468B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5875614A (ja) * 1981-10-28 1983-05-07 Matsushita Electric Ind Co Ltd 焼却炉の排ガス浄化装置
DE4312016A1 (de) * 1993-04-13 1994-10-20 Goedecke Ag Stabile Ketamin-Lösungen
DE19619665C2 (de) * 1996-05-15 2001-03-08 Goedecke Ag Racemattrennung von Ketamin
BRPI0002693B8 (pt) * 2000-06-19 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda processo de obtenção dos enantiômeros da cetamina e seus sais farmaceuticamente aceitáveis
US7273889B2 (en) * 2002-09-25 2007-09-25 Innovative Drug Delivery Systems, Inc. NMDA receptor antagonist formulation with reduced neurotoxicity
US20060063802A1 (en) 2004-03-29 2006-03-23 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US8268866B2 (en) 2004-03-29 2012-09-18 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US9072662B2 (en) 2004-03-29 2015-07-07 Auris Medical Ag Methods for the treatment of tinnitus induced by cochlear excitotoxicity
KR101271263B1 (ko) 2005-09-28 2013-06-07 아우리스 메디칼 아게 내이 장애 치료용 약학 조성물
WO2013087090A1 (en) 2011-12-12 2013-06-20 Auris Medical Ag Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system
US20140274981A1 (en) 2013-03-15 2014-09-18 Janssen Pharmaceutica Nv Pharmaceutical composition of s-ketamine hydrochloride
HUE056378T2 (hu) 2013-09-13 2022-02-28 Univ Chiba Nat Univ Corp R-Ketamin és sójának alkalmazása gyógyszerekként
KR20170040800A (ko) 2014-08-13 2017-04-13 얀센 파마슈티카 엔.브이. 우울증 치료 방법
AU2015318123A1 (en) 2014-09-15 2017-03-30 Janssen Pharmaceutica Nv Val66Met (SNP rs6265) genotype specific dosing regimens and methods for the treatment of depression
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
US20200009081A1 (en) 2017-09-13 2020-01-09 Janssen Pharmaceutica N.V. Delivery Of Esketamine For The Treatment Of Depression
KR20240011237A (ko) 2017-12-22 2024-01-25 얀센 파마슈티카 엔브이 우울증 치료를 위한 에스케타민
US11980595B2 (en) 2018-02-15 2024-05-14 National University Corporation Chiba University Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases
CN110218157B (zh) * 2018-03-01 2022-08-23 江苏恒瑞医药股份有限公司 一种r-氯胺酮及其可药用盐的制备方法
WO2019213551A1 (en) 2018-05-04 2019-11-07 Perception Neuroscience, Inc. Methods of treating substance abuse
BR112020023882A2 (pt) 2018-06-27 2021-02-09 Clexio Biosciences Ltd. método para tratar transtorno depressivo maior
CN112702995A (zh) 2018-10-05 2021-04-23 克雷西奥生物科技有限公司 治疗重度抑郁症的艾氯胺酮的治疗方案
WO2020070547A1 (en) 2018-10-05 2020-04-09 Clexio Biosciences Ltd. Dosage regime of esketamine for treating major depressive disorder
EP3863617A1 (de) 2018-10-11 2021-08-18 Clexio Biosciences Ltd. Esketamin zur verwendung bei der behandlung einer schweren depressiven störung
JP2022524008A (ja) 2019-03-05 2022-04-27 ヤンセン ファーマシューティカルズ,インコーポレーテッド うつ病の治療のためのエスケタミン
WO2021137148A1 (en) 2019-12-30 2021-07-08 Clexio Biosciences Ltd. Dosage regime with esketamine for treating neuropsychiatric or neurological conditions
EP4084786A1 (de) 2019-12-30 2022-11-09 Clexio Biosciences Ltd. Dosierungsschema mit esketamin zur behandlung einer schweren depressiven störung
JP2023507926A (ja) 2019-12-30 2023-02-28 クレキシオ バイオサイエンシーズ エルティーディー. 神経精神状態または神経学的状態を治療するためのエスケタミンを用いた投与計画
JP2023511370A (ja) 2020-01-22 2023-03-17 シーロス セラピューティクス, インコーポレイテッド Nmda拮抗薬の副作用の低減
CN112125816A (zh) * 2020-03-17 2020-12-25 国药集团工业有限公司 一种氯胺酮、其衍生物或其盐的消旋化方法
WO2025057111A1 (en) 2023-09-12 2025-03-20 Clexio Biosciences Ltd. Esketamine or a pharmaceutical salt thereof for use in a method of treating major depressive disorder

Also Published As

Publication number Publication date
FR2081388A1 (de) 1971-12-03
JPS4948542B1 (de) 1974-12-21
ZA708468B (en) 1972-02-23
GB1330878A (en) 1973-09-19
FR2081388B1 (de) 1974-06-21
BE760492A (fr) 1971-06-17
CH535201A (de) 1973-03-31
DE2062620A1 (de) 1971-07-15
NL7018334A (de) 1971-06-22

Similar Documents

Publication Publication Date Title
ES386601A1 (es) Un procedimiento de resolucion de 2-(oclorofenil) - 2- me- tilamino-ciclohexanona racemica.
NL188266B (nl) Werkwijze ter bereiding van een oogheelkundig inplantaat.
CH390916A (de) Verfahren zur Herstellung von pharmakologisch wirksamen organischen Verbindungen
AT269089B (de) Verfahren zur Herstellung organischer Verbindungen
DK126422B (da) Fremgangsmåde til opspaltning af racemiske organiske aminer.
ES386969A1 (es) Un metodo para preparar una amidinourea.
NL7600467A (nl) Werkwijze ter bereiding van wijnsteenzuur.
ES390110A1 (es) Un procedimiento para la preparacion de nuevos compuestos organicos biciclicos.
CH449010A (de) Verfahren zur Herstellung organischer Borverbindungen
CH410941A (de) Verfahren zur Herstellung von organischen Phosphorthioverbindungen
CH553744A (de) Verfahren zur herstellung aromatischer dinitrohalogenverbindungen.
DK357676A (da) Fremgangsmade til fremstilling af organiske forbindelser
NO142864C (no) Fremgangsmaate for asymmetrisk hydrogenering av prochirale eller racemiske forbindelser ved hjelp av amino- eller polyiminoalaner
CH453346A (de) Verfahren zur Herstellung organischer Verbindungen
CH422777A (de) Verfahren zur Herstellung neuer organischer Phosphorverbindungen
ES306001A1 (es) Procedimiento de preparacion de medios fungicidas.
ES413271A1 (es) Un procedimiento para la preparacion de acido 5-fluor-2-me-til-1-(p,metilsulfinilbenciliden)-3-indenil-acetica.
ES285790A1 (es) Procedimiento para la producción de succinimidas
ES461637A1 (es) Un procedimiento para la preparacion de compuestos tiazoli- nil cetobenzimidazoles.
CH381217A (de) Verfahren zur Herstellung a,B-ungesättigter Carbonylverbindungen
DD138471A3 (de) Verfahren zur gezielten herstellung von derivaten nieder-bis hochfluorierter kohlenwasserstoffe
ES408521A1 (es) Un procedimiento de estabilizacion del tetracloroetileno.
CH550150A (de) Verfahren zur herstellung von salzen von bis-(fluoralkylsulfonyl)-methan-verbindungen.
CH437255A (de) Verfahren zur Herstellung von hochfluorierten organischen Verbindungen
ES357243A3 (es) Procedimiento de preparacion de esteres heterociclicos de metil-5-hidroxi-8 quinoleina.